Drug Trial Radar · NCT06597344
A Study in Adolescent and Adult Female Participants to Evaluate Clinical Symptom Improvement and the Safety of Gepotidacin During Treatment of Uncomplicated Urinary Tract Infections (Acute Cystitis)
Last checked: Nov 20, 2026Latest source record: Feb 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
97
Actual
Start
Oct 2, 2024
Primary completion
Mar 10, 2025
Study completion Mar 10, 2025
Sponsor
- Lead sponsor
- GlaxoSmithKlineGSK (GSK)
- Sponsor type
- Industry
- First posted
- Sep 19, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study will be conducted to evaluate the clinical symptom improvement and safety of oral gepotidacin for treatment of uncomplicated UTI (acute cystitis) in adolescent and adult female participants.
Conditions
- Urinary Tract Infections
Interventions
GepotidacinDrug
Gepotidacin will be administered.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants Achieving Clinical Symptom Improvement at 24 Hours (±4 Hours)Time frame: At 24 hours (h) (±4 h)
Locations
22 sites in 1 country. Site status is shown where the registry gives one.
GSK Investigational Site
Modesto, California
GSK Investigational Site
Pasadena, California
GSK Investigational Site
San Diego, California
GSK Investigational Site
Valencia, California
GSK Investigational Site
Miami, Florida
GSK Investigational Site
Ormond Beach, Florida
GSK Investigational Site
Palm Springs, Florida
GSK Investigational Site
Palm Springs, Florida
GSK Investigational Site
Plant City, Florida
GSK Investigational Site
Sweetwater, Florida
GSK Investigational Site
West Palm Beach, Florida
GSK Investigational Site
West New York, New Jersey
GSK Investigational Site
New York, New York
GSK Investigational Site
Dayton, Ohio
GSK Investigational Site
Forney, Texas
GSK Investigational Site
Houston, Texas
GSK Investigational Site
Houston, Texas
GSK Investigational Site
Kingwood, Texas
GSK Investigational Site
Mesquite, Texas
GSK Investigational Site
Missouri City, Texas
GSK Investigational Site
Bountiful, Utah
GSK Investigational Site
Morgantown, West Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.